<DOC>
	<DOC>NCT00305604</DOC>
	<brief_summary>To evaluate the effect of treatment with sitagliptin compared to placebo in elderly patients with type 2 diabetes mellitus who have poor glycemic control with diet and exercise.</brief_summary>
	<brief_title>Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Community dwelling patients 65 years of age or older diagnosed with Type 2 Diabetes not controlled with diet and exercise Patients must have a HbA1c of 710% off medication, or as a result of a protocol washout from oral antihyperglycemic agents by the qualifying visit Patients with type 1 diabetes History of ketoacidosis or requires insulin use Alanine aminotransferase / aspartate aminotransferase &gt; 2.5 X ULN, triglycerides &gt; 600 mg/dL, creatinine clearance &lt; 35 mL/min Fasting plasma glucose consistently &gt; 260 mg/dL Poorly controlled hypertension</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>